Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Remote Pharmacy vs Spry

Remote Pharmacy
Graded #110

Higher grade

vs+13.100000000000009
Spry
Graded #408

Lower grade

The verdict

Remote Pharmacy takes it — 69.9/100 to 56.8/100.

Remote Pharmacy grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Remote Pharmacy is a US direct-to-consumer telehealth service offering compounded GLP-1 weight-loss medication on a cash-pay basis with no subscriptions or hidden fees.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRemote Pharmacy +22
76
54
Dose & formulationRemote Pharmacy +19
83
64
Clinical oversightRemote Pharmacy +11
66
55
Labs & monitoringEven
52
52
FulfillmentRemote Pharmacy +9
70
61
Contract termsRemote Pharmacy +6
61
55
Remote Pharmacy · left barSpry · right bar

The numbers

MetricRemote PharmacySpry
WeighScore69.9/10056.8/100
GradeCC
Scorecard rank#110#408
Semaglutide$167/mo (all doses, compounded)$199/mo (starting dose, compounded)
Tirzepatide$230/mo (all doses, compounded)$299/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Remote Pharmacy

Graded #110 · C

Strengths

  • Low cash-pay pricing with no subscription or hidden fees
  • Free doctor consultation and free shipping (you pay only for medication)
  • Offers injectable and sublingual or tablet forms of both drugs
  • Medication made by 503A-certified compounding facilities

Where it loses points

  • Does not publicly name its specific compounding pharmacies or clinical provider
  • Covered states are not listed on the pages reviewed
  • Newer brand with limited third-party track record
Spry

Graded #408 · C

Strengths

  • Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
  • Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
  • Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
  • No contracts or commitment required
  • LegitScript Certified with a public verification link

Where it loses points

  • Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
  • Intake reviewed by a nurse practitioner, not an MD
  • States served not disclosed publicly
  • Pharmacy partner not named, and 503A vs 503B designation not specified
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard